TEVA PHARMACEUTICALS INTERNATIONAL GMBH

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 54201
 
  
 
C07K PEPTIDES 18118
 
  
 
C07D HETEROCYCLIC COMPOUNDS 17145
 
  
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 1691
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1485
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 940
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 7131
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 5149
 
  
 
C07B GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR 413
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 293

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0055,832 USE OF PRIDOPIDINE FOR TREATING FUNCTIONAL DECLINEAug 24, 17Mar 01, 18[A61K]
2017/0319,640 Formulations and Methods of Administration of Cephalotaxines, Including HomoharringtonineMay 16, 17Nov 09, 17[A61K, C07D]
2017/0266,170 PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPYJun 02, 17Sep 21, 17[A61K]
2017/0182,024 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PARKINSON'S DISEASEMar 11, 15Jun 29, 17[A61K]
2017/0088,612 PREVENTING, TREATING, AND REDUCING (PERSISTENT) POST-TRAUMATIC HEADACHESep 23, 16Mar 30, 17[A61K, C07K]
2017/0037,117 COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERSOct 11, 16Feb 09, 17[C07K]
2017/0020,854 PRIDOPIDINE BASE FORMULATIONS AND THEIR USEJul 22, 16Jan 26, 17[A61K]
2017/0015,696 SOLID STATE FORMS OF SOFOSBUVIRFeb 19, 15Jan 19, 17[C07H]
2016/0193,223 Oral cephalotaxine dosage formsDec 23, 15Jul 07, 16[A61K]
2016/0166,559 DEUTERATED ANALOGS OF PRIDOPIDINE USEFUL AS DOPAMINERGIC STABILIZERSDec 14, 15Jun 16, 16[A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9896502 Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameMar 20, 15Feb 20, 18[A61K, C07K]
9890210 Antagonist antibodies directed against calcitonin gene-related peptideMay 05, 17Feb 13, 18[A61K, C12P, C07K]
9890211 Antagonist antibodies directed against calcitonin gene-related peptideMay 05, 17Feb 13, 18[A61K, C07K]
9884907 Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptideMay 05, 17Feb 06, 18[A61K, C07K]
9884908 Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptideMay 05, 17Feb 06, 18[A61K, C07K]
RE46629 Deuterated catecholamine derivatives and medicaments compromising said compoundsAug 20, 14Dec 12, 17[A61K, C07C, C07B, A61P]
9814706 Hydrobromide salt of pridopidineFeb 04, 15Nov 14, 17[A61K, A01N, C07D]
9796673 L-tartrate salt of pridopidineDec 18, 15Oct 24, 17[C07D, C07C]
9763904 Position-specific asymmetric deuterium enriched catecholamine derivatives and medicaments comprising said compoundsJan 10, 17Sep 19, 17[A61K]
9764130 Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresisMay 13, 13Sep 19, 17[A61N, A61M]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0275,352 Methods of Treating Chronic PainAbandonedNov 02, 16Sep 28, 17[A61K, C07K]
2017/0112,779 POLYAMINE ENHANCED FORMULATIONS FOR TRIPTAN COMPOUND IONTOPHORESISAbandonedJul 29, 16Apr 27, 17[A61K, A61N]
2017/0081,395 ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE AND METHODS USING SAMEAbandonedMay 05, 16Mar 23, 17[C07K]
2017/0073,398 METHODS OF TREATING INFLAMMATORY PAINAbandonedApr 21, 16Mar 16, 17[A61K, C07K]
2017/0073,412 METHODS FOR TREATING VISCERAL PAIN BY ADMINISTERING ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDEAbandonedApr 21, 16Mar 16, 17[C07K]
2017/0044,243 METHODS OF TREATING CHRONIC PAINAbandonedMar 25, 16Feb 16, 17[C07K]
2016/0317,495 PHARMACOKINETICS OF IONTOPHORETIC SUMATRIPTAN ADMINISTRATIONAbandonedJul 12, 16Nov 03, 16[A61K, A61N]
2016/0095,847 DEUTERATED ANALOGS OF PRIDOPIDINE USEFUL AS DOPAMINERGIC STABILIZERSAbandonedDec 14, 15Apr 07, 16[A61K]
2015/0216,794 METHODS OF TREATING PAIN ASSOCIATED WITH OSTEOARTHRITIS OF A JOINT WITH A TOPICAL FORMULATION OF A SPIRO-OXINDOLE COMPOUNDAbandonedFeb 05, 15Aug 06, 15[A61K]
2014/0314,767 METHODS FOR TREATING VISCERAL PAIN BY ADMINISTERING ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDEAbandonedOct 18, 13Oct 23, 14[C07K]
2014/0308,290 METHODS FOR TREATING VISCERAL PAIN BY ADMINISTERING ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDEAbandonedJun 04, 14Oct 16, 14[C07K]
2014/0163,452 PHARMACOKINETICS OF IONTOPHORETIC SUMATRIPTAN ADMINISTRATIONAbandonedNov 01, 13Jun 12, 14[A61K, A61N]
2013/0295,087 METHODS OF TREATING CHRONIC PAINAbandonedMay 10, 13Nov 07, 13[A61K]
2013/0295,088 METHODS OF TREATING INFLAMMATORY PAINAbandonedMay 10, 13Nov 07, 13[A61K]
2013/0267,552 PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPYAbandonedApr 03, 13Oct 10, 13[A61K]
2013/0245,535 POLYAMINE ENHANCED FORMULATIONS FOR TRIPTAN COMPOUND IONTOPHORESISAbandonedJan 17, 13Sep 19, 13[A61N]
2013/0197,031 DEUTERATED ANALOGS OF PRIDOPIDINE USEFUL AS DOPAMINERGIC STABILIZERSAbandonedAug 31, 11Aug 01, 13[C07D]
2013/0018,298 Iontophoretic Drug Delivery PackagingAbandonedSep 20, 12Jan 17, 13[A61N, B65B]
2012/0058,991 Formulations and Methods of Administration of Cephalotaxines, Including HomoharringtonineAbandonedNov 11, 11Mar 08, 12[A61K, C07D, A61P]
2011/0293,676 Oral Cephalotaxine Dosage FormsAbandonedAug 11, 11Dec 01, 11[A61K, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.